Catecholamine release mechanisms

Catecholamine release mechanisms refer to the physiological pathways through which biogenic amines, including dopamine, norepinephrine, and epinephrine, are secreted from neurons and endocrine cells. This process primarily involves the sequestration of these molecules into synaptic vesicles by the vesicular monoamine transporter 2 (VMAT2), followed by their release into the synaptic cleft or systemic circulation via calcium-triggered exocytosis (StatPearls, 2023). In the sympathetic nervous system, this release is a critical component of the fight-or-flight response, regulating heart rate, blood pressure, and glucose metabolism. Drugs targeting these mechanisms include indirect-acting sympathomimetics like amphetamines, which induce non-exocytotic release, and adrenergic neuron blockers like reserpine, which deplete vesicular stores (DrugBank, 2024). Abnormalities in catecholamine release are central to the pathophysiology of disorders such as Attention Deficit Hyperactivity Disorder (ADHD), Parkinson's disease, and pheochromocytoma. Consequently, these mechanisms serve as vital therapeutic focal points for managing neuropsychiatric and cardiovascular conditions (NCBI, 2022).

Other names

Catecholamine secretionExocytotic release of catecholaminesSympathomimetic release mechanismsAdrenergic neurotransmission release

Modulation of catecholamine availability through stimulation of non-exocytotic release via transporter reversal, inhibition of vesicular storage, or blockade of exocytotic machinery.